
EMA Determines Certain Drugs Safe from Zika Contamination
The agency has confirmed that patients who take plasma- or urine-derived drugs are not at increased risk for Zika.
On Sept. 21, 2016, the European Medicines Agency (EMA)
EMA’s Committee for Medicinal Products for Human Use (CHMP)
According to EMA, plasma-derived drugs, which are manufactured from human blood, include coagulation factors and immunoglobulins. Urine-derived products, which are manufactured from pooled human urine, include hormone-based treatments and urokinase products.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.